Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
Open Access
- 17 August 2022
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2022, 1-11
Abstract
Chagas disease, caused by the protozoa parasite Trypanosoma cruzi, is a neglected tropical disease and a major public health problem affecting more than 6 million people worldwide. Many challenges remain in the quest to control Chagas disease: the diagnosis presents several limitations and the two available treatments cause several side effects, presenting limited efficacy during the chronic phase of the disease. In addition, there are no preventive vaccines or biomarkers of therapeutic response or disease outcome. Trypomastigote form and T. cruzi-infected cells release extracellular vesicles (EVs), which are involved in cell-to-cell communication and can modulate the host immune response. Importantly, EVs have been described as promising tools for the development of new therapeutic strategies, such as vaccines, and for the discovery of new biomarkers. Here, we review and discuss the role of EVs secreted during T. cruzi infection and their immunomodulatory properties. Finally, we briefly describe their potential for biomarker discovery and future perspectives as vaccine development tools for Chagas Disease.Keywords
Funding Information
- Spanish Ministry of Science, Innovation and Universities (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Unión Europea–NextGenerationEU (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Ministerio de Ciencia e Innovación (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Instituto de Salud Carlos III (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- CIBER-Consorcio Centro de Investigación Biomédica en Red (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Fundació la Marató de TV3 (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (CEX2018-000806-S, CB 2021, 566/U/2018, 302104/2019-4, 408186/2018-6, 2020/07870-4, 2019/15909-0)
This publication has 84 references indexed in Scilit:
- Toxoplasma gondii infection of fibroblasts causes the production of exosome‐like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvationJournal of Extracellular Vesicles, 2013
- Vesicles as carriers of virulence factors in parasitic protozoan diseasesMicrobes and Infection, 2012
- Extracellular Vesicles from Parasitic Helminths Contain Specific Excretory/Secretory Proteins and Are Internalized in Intestinal Host CellsPLOS ONE, 2012
- Improved Proteomic Approach for the Discovery of Potential Vaccine Targets in Trypanosoma cruziJournal of Proteome Research, 2011
- Exosomes from Plasmodium yoelii-Infected Reticulocytes Protect Mice from Lethal InfectionsPLOS ONE, 2011
- Augmented plasma microparticles during acute Plasmodium vivax infectionMalaria Journal, 2010
- Chagas disease: a new worldwide challengeNature, 2010
- Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory responseMicrobes and Infection, 2009
- Toxoplasma gondiiAntigen-Pulsed-Dendritic Cell-Derived Exosomes Induce a Protective Immune Response againstT. gondiiInfectionInfection and Immunity, 2004
- Plasma membrane vesicles isolated from epimastigote forms of trypanosoma cruziBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979